CaP Biomaterials

CaP Biomaterials manufactures calcium phosphate materials that can be incorporated into many types of medical devices by medical device manufacturers. Because of diversity of applications it is CaP Biomaterial’s policy to work with customers in the process of choosing the calcium phosphate product requirements/specifications. This often results in supplying a customized product exactly suited to the end use.

CaP and customer come to agreement on material requirements and preparedraft product specifications.

read more

watch the video

Hydroxyapatite porous granulate

Decide if an existing material is suitable or a custom material is needed.


  • Porous granulates of:
    • Hydrxyapatite
    • Tricalcalcium phsphate
    • Mixtures f hydroxyapatite and tricalcium phosphate
  • Hydroxyapatite powder for plasma spraying
  • Calcium phosphate powders of many different compositions for incorporation into polymers
  • Metastable calcium phosphate powders (tetracalcium phosphate; alpha-TCP) for producing self-setting cements
  • Finished self-setting cement powder

CaP Biomaterials prepares/supplies development samples so customer can test the concept.

CaP carries out extensive testing on the prototype product including:

  • XRD analysis for phase composition
  • optical image analysis for pore size, porosity, and particle size
  • surface area analysis (if requested)
  • dissolution and/or solubility (if requested)
  • trace metals analysis


read more

Product specifications are discussed with customer and may be revised.

Prepare batches for customer to use in their process/product validation (if requested).


  • Hydroxyapatite coated implant
  • Collagen strip with ceramic particles
  • Putty with ceramic particles
  • Tray package filled with ceramic particles

read more

watch the video

Go to article: Home | Trump's Tariffs: The Industry ImpactGo to article: In This Issue Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: ContentsGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: NewsGo to article: Abbott & CoGo to article: The Medical Industry Briefing Go to article: Caeleste Company Insight Go to article: CaelesteGo to article: Destroying tumors with next generation ablationGo to article: IMT Company InsightGo to article: IMTGo to article: 5 things to know about Germany’s gesund medical device marketGo to article: MikronGo to article: The hesitancy hurdle: how tech can improve adult vaccination ratesGo to article: Erdmann Design Company Insight Go to article: Erdmann Design Go to article: How is America’s trade war with China undermining the medical device industry?Go to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: A trick of the light: photodynamic therapy illuminates healthcareGo to article: SartoriusGo to article: The budding promise of 3D biopsiesGo to article: Cap BiomaterialsGo to article: Predicting cardiac risk: new approaches in AI and blood testingGo to article: NHP Electrical Engineering ProductsGo to article: Minimally invasive surgery for the masses: under the skin of CMR SurgicalGo to article: ECGs to become part of everyday healthcareGo to article: Astellas Pharma and Frequency Therapeutics collaborate on hearing loss therapyGo to article: BAROnova shuttling towards less invasive weight loss surgeryGo to article: Another case solved by direct-to-consumer genetic testingGo to article: Ethicon targets biosurgery market with next-generation tissue sealantGo to article: EventsGo to article: Next Issue